COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series-Reference-Cited by-同舟云学术

COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series

Published:2023-04 Issue:4 Volume:26 Page:106506
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Walmsley Sharon L.,Szadkowski Leah,Wouters Bradly,Clarke Rosemarie,Colwill Karen,Rochon Paula,Brudno Michael,Ravindran Rizanni,Raboud Janet,McGeer Allison,Oza Amit,Graham Christopher,Silva Amanda,Manase Dorin,Maksymowsky Peter,Parente Laura,Dayam Roaya Monica,Simpson Jacqueline,Pasculescu Adrian,Gingras Anne-Claude

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference62 articles.

1. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults;Anderson;N. Engl. J. Med.,2020

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med. Overseas. Ed.,2021

3. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine;Polack;N. Engl. J. Med.,2020

4. Safety and immunogenicity of two RNA-based covid-19 vaccine candidates;Walsh;N. Engl. J. Med.,2020

5. Protection of BNT162b2 vaccine booster against covid-19 in Israel;Bar-On;N. Engl. J. Med.,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination;Vaccines;2024-05-22

2. Quantitating SARS-CoV-2 Neutralizing Antibodies from Human Dried Blood Spots;2024-03-20

3. Effect of the number of coronavirus disease 2019 (COVID-19) vaccination shots on the occurrence of pneumonia, severe pneumonia, and death in SARS-CoV-2-infected patients;Frontiers in Public Health;2024-01-08

4. Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination;Vaccines;2023-12-28

5. Therapeutic Vaccination Is the Most Promising Intervention for Long COVID;American Journal of Therapeutics;2023-05-26